Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin

Introduction: Kidney fibrosis has shown to be ameliorated through the involvement of cyclic guanosine monophosphate (cGMP) and its dependent protein kinase I (cGKI). Serelaxin, the recombinant form of human relaxin-II, increases cGMP levels and has shown beneficial effects on kidney function in acut...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Pharmacol
Auteurs principaux: Wetzl, Veronika, Schinner, Elisabeth, Kees, Frieder, Hofmann, Franz, Faerber, Lothar, Schlossmann, Jens
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2016
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4940422/
https://ncbi.nlm.nih.gov/pubmed/27462268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00195
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires